Uncategorized
HYPITAT-II: Immediate Delivery or Expectant Management for Non-Severe Hypertension at 34 – 37 weeks?
ISUOG Recommendations: Fetal Ultrasound Follow-Up for Women with Established Preeclampsia
Results from the SPREE Trial: How Does First Trimester Preeclampsia Screening Compare to Current Guidelines?
Consensus Statement: Screening for Early-Onset Preeclampsia and Aspirin Prophylaxis in the US
FIGO First Trimester Preeclampsia Screening Guidelines: Prevention Using Clinical Information and Biomarkers
ISUOG Recommendations for Preeclampsia Prevention: Combined Screening and the Role of Ultrasound
When to Introduce Aspirin to Reduce Risks of Preeclampsia?
Does Enoxaparin Prevent Preeclampsia?
ASPRE Trial: A Combined Risk Algorithm and Use of Aspirin to Prevent Preterm Preeclampsia
